Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Ocular Therapeutix (OCUL) over the last 11 years, with Sep 2025 value amounting to 0.13.

  • Ocular Therapeutix's Asset Utilization Ratio rose 6.09% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year increase of 6.09%. This contributed to the annual value of 0.18 for FY2024, which is 38.36% down from last year.
  • Ocular Therapeutix's Asset Utilization Ratio amounted to 0.13 in Q3 2025, which was down 2.12% from 0.13 recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Asset Utilization Ratio ranged from a high of 0.43 in Q2 2023 and a low of 0.09 during Q1 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.22, with a median of 0.14 in 2025.
  • Per our database at Business Quant, Ocular Therapeutix's Asset Utilization Ratio spiked by 186.87% in 2022 and then crashed by 73.39% in 2024.
  • Ocular Therapeutix's Asset Utilization Ratio (Quarterly) stood at 0.21 in 2021, then surged by 62.42% to 0.33 in 2022, then declined by 15.69% to 0.28 in 2023, then plummeted by 52.35% to 0.13 in 2024, then climbed by 6.09% to 0.13 in 2025.
  • Its Asset Utilization Ratio stands at 0.13 for Q3 2025, versus 0.13 for Q2 2025 and 0.14 for Q1 2025.